AI for Global Health Access
Riovic Bio leverages large quantitative models to provide medicines and medical equipment to remote and underserved communities.
Building the future of biotech with LQMs
Our R&D department is at the forefront of the healthcare industry, creating a network of clinical laboratories that empower underserved communities through technological innovation.
Democratizing Healthcare
We aim to make advanced medicines and medical equipment accessible to remote and underserved communities, bridging the global health gap with our decentralized lab network.
Accelerating Research
Our large quantitative models (LQMs) analyze vast amounts of data, speeding up drug development, biomarker discovery, and clinical trial optimization.
Empowering Innovation
We provide a unified platform that connects researchers and clinical labs, enabling seamless data sharing, collaboration, and rapid scaling of new biotechnologies.
Our Key Research Focus Areas
Our dedicated team is working on solutions to address some of the most pressing health challenges.
Drug Discovery and Optimization
Our use of LQMs drastically accelerates the drug discovery process, from identifying promising molecular targets to optimizing compound design and predicting clinical trial outcomes.
Biomarker Discovery
We develop new methods for identifying and validating biomarkers, leading to earlier disease detection and more personalized treatments.
Genomic Medicine
Our research explores how to use an individual's genetic information to guide their medical decisions, from diagnosis to treatment.
Precision Medicine
We are dedicated to creating low-cost, mobile-first solutions that make high-quality, personalized healthcare available to everyone.
Synthetic Biology
We engineer biological systems and organisms to create new tools and products, from disease diagnostics to novel therapeutics.
Bioinformatics
Our team uses computational methods to analyze and interpret biological data, accelerating research in genomics and drug discovery.
Clinical Trials
We work to optimize clinical trial designs and implement innovative methods to bring new treatments to market faster and more efficiently.
Regenerative Therapies
Our research includes exploring therapies that restore and regenerate damaged tissues and organs to improve health outcomes.
Genetic Engineering
We work on advanced gene editing technologies to correct genetic diseases and create new biological systems for therapeutic use.
Microbiome Analysis
Our research leverages advanced analysis of the human microbiome to understand its role in health and disease and to develop new interventions.